Complaint in Louisiana Federal Court Targets Osteoporosis Medication Actonel

Another osteoporosis drug is targeted in litigation as a Louisiana woman sued the manufacturers of Actonel in a federal court in Louisiana July 3, alleging Actonel’s makers failed to warn her and the medical community about the dangers of thigh bone (atypical femur) fracture (Baudean v. Procter & Gamble Pharmaceuticals Inc.).

Anita Beaudean alleges she used Actonel, an oral bisphosphonate drug, for nine years. In July 2011, she fractured her right femur. The break required surgical repair involving placement of a rod and pins. She sued makers Procter & Gamble Pharmaceuticals Inc., parent company Warner-Chilcott Pharmaceuticals Inc., and ...